Clinical trial

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

NCT01036087

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Panitumumab Normalized identity: panitumumabView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Nab-paclitaxel Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 5-Fluorouracil Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Epirubicin Normalized identity: epirubicinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cyclophosphamide Normalized identity: cyclophosphamideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-11-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

PanitumumabDRUG · verified · RxNorm: panitumumab

Nab-paclitaxelDRUG

CarboplatinDRUG · verified · RxNorm: carboplatin

5-FluorouracilDRUG

EpirubicinDRUG · verified · RxNorm: epirubicin

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

Celgene Corporationcollaborator

Amgencollaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01036087 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.